Clinical Trials
3 trialsNCT02538341 2021-11-23
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
Phase 2 Completed
NCT01767467 2018-06-06
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
GlaxoSmithKline
Phase 3 Completed
NCT02444936 2018-04-06
ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
Louis Stokes VA Medical Center
Phase 4 Unknown